Tectonic Therapeutic Inc (TECX)
41.04
-0.98 (-2.33%)
At close: Jan 17, 2025, 3:59 PM
40.90
-0.34%
After-hours Jan 17, 2025, 04:00 PM EST
Company Description
No Company description available at the moment.
Tectonic Therapeutic Inc
| Country | n/a |
| IPO Date | n/a |
| Industry | n/a |
| Sector | n/a |
| Employees | 44 |
| CEO | Dr. Alise S. Reicin M.D., Ph.D. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | US8789721086 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Alise S. Reicin M.D., Ph.D. | President, Chief Executive Officer, Secretary & Director |
| Daniel Lochner M.B.A. | Chief Financial Officer |
| Anthony Muslin M.D. | Chief Development Officer |
| Barry Rubenstein M.S. | Senior Vice President of People & Culture |
| Dr. Marc Schwabish Ph.D. | Chief Business Officer |
| Dr. Peter McNamara Ph.D. | Chief Scientific Officer |
| John Diener | Senior Vice President of Antibody Engineering & Protein Sciences |